Skip to main content
Have a personal or library account? Click to login
Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats Cover

Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats

Open Access
|Dec 2010

References

  1. S. Miyamoto, G. E. Duncan, C. E. Marx and J. A. Lieberman, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs,(2005) 79-104; DOI: 10.1038/sj.mp.4001556.
  2. S. Natesan, G. E. Reckless, K. B. Barlow, J. N. Nobrega and S. Kapur, Amisulpride the ‘atypical’ atypical antipsychotic-comparison to haloperidol, risperidone and clozapine,(2008) 224-235; DOI: 10.1016/j.schres.2008.07.005.
  3. V. Bigliani, R. S. Mulligan, P. D. Acton, D. Visvikis, P. J. Ellm, C. Stephenson, R. W. Kerwin and L. S. Pilowsky, In vivo occupancy of striatal and temporal cortical D/Ddopamine receptors by typical antipsychotic drugs. [123I] epidepride single photon emission tomography (SPET) study,(1999) 231-238; DOI: 10.1192/bjp.175.3.231.
  4. S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li and J. M. Davis, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis,(2009) 31-41; DOI: 10.1016/S0140-6736(08)61764-X.
  5. M. L. Wadenberg, S. Kapur, A. Soliman, C. Jones and F. Vaccarino, Dopamine Dreceptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats,(2000) 422-429; DOI: 10.1007/s002130000466.
  6. J. T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn and J. D. Salamone, Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function,(1997) 74-81; DOI: 10.1007/s002130050322.
  7. S. Kapur and P. Seeman, Does fast dissociation from the dopamine Dreceptor explain the action of atypical antipsychotics?: A new hypothesis,(2000) 360-369; DOI: 10.1176/appi.ajp.158.3.360.
  8. A. Newman, C. Chaput, L. Verriele and M. J. Millan, Clozapine is a partial agonist at cloned human serotonin 5-HTreceptors,(1996) 119-121; DOI: 10.1016/0028-3908 (95)00170-0.
  9. S. Szymanski, J. Lieberman, S. Pollack, R. Munne, A. Safferman, J. Kane, M. Kronig and T. Cooper, The dopamine-serotonin relationship in clozapine response,(1993) S85-S89; DOI: 10.1007/BF02245011.
  10. M. Campbell, P. I. Young, D. N. Bateman, J. M. Smith and S. H. Thomas, The use of atypical antipsychotics in the management of schizophrenia,(1999) 13-22; DOI: 10.1046/j.1365-2125.1999.00849.x.
  11. R. Kumar, G. Palit and B. N. Dhawan, Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey,(2003) 133-138; DOI: 10.1016/S0014-2999(02)02957-6.
  12. R. A. Bressan, K. Erlandsson, H. M. Jones, R. S. Mulligan, P. J. Ell and L. S. Pilowsky, Optimizing limbic selective D/Dreceptor occupancy by risperidone: a [123I]-epidepride SPET study,(2003) 5-14; DOI: 10.1097/00004714-200302000-00002.
  13. D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. S. Saify and M. A. Haleem, Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats,(2002) 354-361.
  14. F. Batool, S. Ahmed and D. J. Haleem, Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex,(2009) 139-145.
  15. D. J. Haleem, Z. S. Saify, S. Siddiqui, F. Batool and M. A. Haleem, Pre- and postsynaptic responses to 1-(1-naphthylpiperazine) following adaptation to stress in rats,(2002) 149-56; DOI: 10.1016/S0278-5846(01)00240-8.
  16. L. S. Pilowsky, D. C. Costa, P. J. Ell, N. P. Verhoeff, R. M. Murray and R. W. Kerwin, Ddopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study,(1994) 16-26; DOI: 10.1192/bjp.164.1.16.
  17. Q. C. Meng, Y. F. Chen and S. Oparil, A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC,(1989) 1207-1213; DOI: 10.1016/0024-3205(89)90316-0.
  18. N. Samad, F. Batool and D. J. Haleem, Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats,(2007) 173-180.
  19. J. de Jong, U. R. Tjaden, E. Visser and W. H. Meijer, Determination of serotonin and 5-hydroxy-indoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorimetric detection,(1987) 85-94.
  20. L. Farde, A. L. Nordstrom, F. A. Wiesel, S. Pauli, C. Halldin and G. Sedvall, Positron emission tomographic analysis of central Dand Ddopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects,(1992) 538-544; DOI: 10.1016/0024-3205(78)90035-8.
  21. T. J. Crow, E. C. Johnstone, A. J. Longden and F. Owen, Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process,(1978) 563-567; DOI: 10.1016/0024-3205(78)90035-8.
  22. D. Pickar, T. P. Su, D. R. Weinberger, R. Coppola, A. K. Malhotra, M. B. Knable, K. S. Lee, J. Gorey, J. J. Bartko, A. Breier and J. Hsiao, Individual variation in Ddopamine receptor occupancy in clozapine-treated patients,(1996) 1571-1578.
  23. H. Y. Meltzer and M. Huang,actions of atypical antipsychotic drug on serotonergic and dopaminergic systems,(2008) 177-197; DOI: 10.1016/S0079-6123(08)00909-6.
  24. X. Xiberas, J. L. Martinot, L. Mallet, E. Artiges, C. Loc'H, B. Mazière and M. L. Paillère-Martinot, Extrastriatal and striatal Ddopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia,(2001) 503-508; DOI: 10.1192/bjp.179.6.503.
  25. S. Nyberg, L. Farde, L. Eriksson, C. Halldin and B. Eriksson, 5-HTand Ddopamine receptor occupancy in the living human brain. A PET study with risperidone,(1993) 265-272; DOI: 10.1007/BF02251280.
DOI: https://doi.org/10.2478/v1007-010-0014-y | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 129 - 140
Published on: Dec 6, 2010
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2010 Farhat Batool, Ambreen Hasnat, Muhammad Haleem, Darakhshan Haleem, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.